Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.
Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
HIGH-FREQUENCY failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal needs causing maternal NON-ADHERENCE.
Dynamics of the decay of HIV RNA and distribution of bictegravir in the genital tract and rectum in antiretroviral-naïve HIV-1-infected adults treated with bictegravir/emtricitabine/tenofovir alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58).
Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1.
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent.
Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control.
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Safety of Anti-PD-L1 Inhibition in HIV-1-Infected Patients With Cancer-Reply.
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).